SEC Filing Summary: AquaBounty Technologies, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AquaBounty Technologies, Inc. on April 16, 2019, with the earliest event reported on April 4, 2019. The filing details the consummation of an underwritten public offering of common stock. The Company is designated as an emerging growth company.
Key Financial Metrics
The filing focuses on capital raising activities rather than operational performance metrics. Specific figures regarding the offering are as follows:
- Shares Sold: 346,488 Option Shares (partial exercise of over-allotment).
- Offering Price: $2.25 per share.
- Gross Proceeds: Approximately $0.78 million.
- Net Proceeds: Approximately $0.71 million (after underwriting discounts and commissions).
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions outside of the proceeds from this specific transaction.
Material Changes
The primary material change is the increase in the Company's cash position due to the sale of Option Shares. This transaction completed the partial exercise of the over-allotment option granted to underwriters on April 4, 2019, which was originally for up to 383,188 shares. The Company sold 346,488 of these shares.
Outlook, Risks, and Management Commentary
Management commentary is limited to the confirmation of the transaction's completion and the issuance of a press release on April 17, 2019. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard disclosure that the offering was made pursuant to a prospectus supplement and Registration Statement on Form S-3.
Key Facts for Investor Verification
- Verify the total number of shares outstanding post-transaction to assess dilution impact.
- Confirm the use of the approximately $0.71 million in net proceeds as disclosed in the press release (Exhibit 99.1).
- Review the full prospectus supplement dated April 5, 2019, for details on the Firm Shares sold earlier in the offering.
- Check subsequent filings for the status of the remaining unexercised over-allotment option (36,700 shares).